Sign in
Facet browsing currently unavailable
Page 5 of 2476 results
Sort by: relevance publication year
|
Friday 4 December - Oral Presentations JOURNAL ARTICLE published April 2020 in Antiviral Therapy |
|
Aging, Frailty, Disability & Immune Senescence JOURNAL ARTICLE published July 2019 in Antiviral Therapy |
|
Book Review: Clinical Virology JOURNAL ARTICLE published April 1998 in Antiviral Therapy |
|
Vertebral Osteonecrosis in An HIV-Infected Patient JOURNAL ARTICLE published November 2012 in Antiviral Therapy |
|
Relative Impact of Ribavirin Monitoring and HIV Coinfection on Sustained Virological Response in Patients with Chronic Hepatitis C JOURNAL ARTICLE published November 2011 in Antiviral Therapy |
|
Significant Interaction between Activated Charcoal and Antiretroviral Therapy Leading to Subtherapeutic Drug Concentrations, Virological Breakthrough and Development of Resistance JOURNAL ARTICLE published July 2013 in Antiviral Therapy |
|
Oral Presentations JOURNAL ARTICLE published July 2019 in Antiviral Therapy |
|
The NIQ of Lopinavir is Predictive of a 48-Week Virological Response in Highly Treatment-Experienced HIV-1-Infected Subjects Treated with a Lopinavir/Ritonavir-Containing Regimen JOURNAL ARTICLE published May 2004 in Antiviral Therapy |
|
Incident Hyperglycaemia among Older Adults with or At-Risk for HIV Infection JOURNAL ARTICLE published February 2011 in Antiviral Therapy |
|
Safety, tolerability and pharmacokinetics of orally inhaled zanamivir: a randomised study comparing Rotacap/Rotahaler and Rotadisk/Diskhaler in healthy adults JOURNAL ARTICLE published 2013 in Antiviral Therapy |
|
Factors Impacting the Provision of Antiretroviral Therapy to People Living with HIV: The View from Haiti JOURNAL ARTICLE published April 2014 in Antiviral Therapy |
|
Inhibition of chikungunya virus replication by N-ω-Chloroacetyl-L-Ornithine in C6/36, Vero cells and human fibroblast BJ JOURNAL ARTICLE published February 2023 in Antiviral Therapy Research funded by Instituto Politécnico Nacional (SIP 20195289) |
|
Failure of Lamivudine to Reverse Hepatitis B Virus-Associated Changes in ERK, Akt and Cell Cycle Regulatory Proteins JOURNAL ARTICLE published February 2008 in Antiviral Therapy |
|
Systematic Review to Determine the Prevalence of Transmitted Drug Resistance Mutations to Rilpivirine in HIV-Infected Treatment-Naive Persons JOURNAL ARTICLE published July 2016 in Antiviral Therapy |
|
Similar Predictions of Etravirine Sensitivity Regardless of Genotypic Testing Method Used: Comparison of Available Scoring Systems JOURNAL ARTICLE published November 2012 in Antiviral Therapy |
|
Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression JOURNAL ARTICLE published February 2009 in Antiviral Therapy |
|
A baseline model including quantitative anti-HBc to predict response of peginterferon in HBeAg-positive chronic hepatitis B patients JOURNAL ARTICLE published November 2021 in Antiviral Therapy |
|
Three-Year Clinical Outcomes of Resistance Genotyping and Expert Advice: Extended follow-up of the Argenta Trial JOURNAL ARTICLE published April 2006 in Antiviral Therapy |
|
Clinically Validated Genotype Analysis: Guiding Principles and Statistical Concerns JOURNAL ARTICLE published May 2004 in Antiviral Therapy |
|
Impact of Lamivudine on the Risk of Liver-Related Death in 2,041 Hbsag- and HIV-Positive Individuals: Results from An Inter-Cohort Analysis JOURNAL ARTICLE published July 2006 in Antiviral Therapy |